BZAM Ltd. (BZAMF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Aug 20, 2025, 4:00 PM EDT
BZAM Ltd. Market Cap
BZAM Ltd. has a market cap or net worth of $271.00 as of August 21, 2025. Its market cap has decreased by -100.00% in one year.
Market Cap
271.00
Enterprise Value
n/a
Revenue
60.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 3, 2018, BZAM Ltd.'s market cap has decreased from 597.36M to 271.00, a decrease of -100.00%. That is a compound annual growth rate of -86.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2025 | 271.00 | - |
| Dec 31, 2024 | 271.00 | -100.00% |
| Dec 29, 2023 | 16.46M | -58.59% |
| Dec 30, 2022 | 39.76M | -28.70% |
| Dec 31, 2021 | 55.76M | -36.09% |
| Dec 31, 2020 | 87.25M | -51.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 3, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 610.45M |
| Glass House Brands | 554.44M |
| Nika Pharmaceuticals | 453.04M |
| American Oncology Network | 398.51M |
| CytoDyn | 365.94M |
| Northwest Biotherapeutics | 355.76M |